Residential College | false |
Status | 已發表Published |
Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy | |
Wang S.1; Xu Y.1; Chan H.F.2; Kim H.-W.3; Wang Y.1; Leong K.W.2; Chen M.1 | |
2016 | |
Source Publication | Journal of Controlled Release |
ISSN | 0168-3659 |
Volume | 240Pages:454 |
Abstract | The acquired resistance of human cancer cells to apoptosis is one of the defining hallmarks of cancer. Upregulated expression of inhibitors of apoptosis proteins (IAP) has been implicated in drug resistance in several cancers. Survivin (encoded by BIRC5), the smallest member of the IAP family, has been correlated with both the control of cell apoptosis and regulation of cell mitosis in cancer. Owing to its critical role in regulation of cell survival and development of cancer resistance, as well as its distinguishingly high level of expression in many types of cancer, survivin has long been regarded as a promising therapeutic target for cancer therapy. This review first presents an overview of the mechanism by which survivin regulates cell function, followed by a discussion of the current state of survivin-targeted therapies. We focus on the application of nanoparticulate systems to deliver survivin inhibitors, co-delivery of survivin inhibitors with chemotherapeutic agents, synchronous targeting of survivin, other drug resistant molecules, and survivin regulators. We conclude by highlighting the current limitations associated with survivin-targeted therapies and speculating on the future strategies to surmount these impediments. © 2016 Elsevier B.V. |
Keyword | Apoptosis Cancer Drug Resistance Nanoparticles Survivin |
DOI | 10.1016/j.jconrel.2016.04.018 |
URL | View the original |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Chemistry ; Pharmacology & Pharmacy |
WOS Subject | Chemistry, Multidisciplinary ; Pharmacology & Pharmacy |
WOS ID | WOS:000386250700036 |
The Source to Article | Scopus |
Scopus ID | 2-s2.0-84964754237 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | Institute of Chinese Medical Sciences |
Corresponding Author | Leong K.W.; Chen M. |
Affiliation | 1.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of MacauMacau, China 2.Department of Biomedical Engineering, Columbia University, New York, NY 10027, United States 3.Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, 330-714, South Korea |
First Author Affilication | Institute of Chinese Medical Sciences |
Corresponding Author Affilication | Institute of Chinese Medical Sciences |
Recommended Citation GB/T 7714 | Wang S.,Xu Y.,Chan H.F.,et al. Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy[J]. Journal of Controlled Release, 2016, 240, 454. |
APA | Wang S.., Xu Y.., Chan H.F.., Kim H.-W.., Wang Y.., Leong K.W.., & Chen M. (2016). Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy. Journal of Controlled Release, 240, 454. |
MLA | Wang S.,et al."Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy".Journal of Controlled Release 240(2016):454. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment